The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19.
Christiana MantzouraniSofia VasilakakiVelisaria-Eleni GerogianniGeorge KokotosPublished in: Expert opinion on drug discovery (2022)
studies and clinical trials will give a clear answer if TMPRSS2 inhibitors could be a new weapon against COVID-19.